Immuneering Corporation (IMRX) Operating income 2020–2025
Immuneering Corporation (IMRX) annual operating income history from SEC filings — each fiscal year as reported.
-$59.4MFY2025 · since FY2020: -$17.1M → -$59.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$59.4M | +7.3% |
| FY2024 | -$64.1M | -9.7% |
| FY2023 | -$58.4M | -12.9% |
| FY2022 | -$51.7M | -52.7% |
| FY2021 | -$33.9M | -98.4% |
| FY2020 | -$17.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice